1. bookVolume 75 (2021): Issue 3 (June 2021)
Journal Details
License
Format
Journal
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
access type Open Access

Narrow-Band UVB Therapy and Topical Calcineurin Inhibitors for the Treatment of Paediatric Vitiligo in Real Clinical Practice

Published Online: 22 Jul 2021
Page range: 200 - 205
Received: 15 Jul 2020
Accepted: 24 Jan 2021
Journal Details
License
Format
Journal
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
Abstract

Vitiligo is an acquired chronic skin disease, characterised by progressing, usually symmetric, depigmented areas in human skin. Vitiligo affects 0.5% of the human population, however, optimal treatment combination real clinical practice has yet to be found. The aim of the study was to assess whether combined therapy with ultraviolet B (UVB) therapy and calcineurin inhibitors (CNI) provides superior response in vitiligo patients, compared with phototherapy or topical CNI monotherapy. We performed a retrospective cohort study of children treated for vitiligo from January 2016 to December 2019. Primary outcome measures include clinical efficacy defined by area of repigmentation — good clinical efficacy (re-pigmentation of ≥ 50% of lesion surface area), positive clinical efficacy and poor clinical efficacy (re-pigmentation of < 15% of lesion surface area). Secondary outcome measures included reduction of lesion size and tolerability of therapy. A total of 114 patients were recruited in the study, 46 allocated to the topical CNI therapy group, 36 to the narrow band (Nb-UVB), and 32 to the combined therapy group. All treatments statistically significantly decreased lesion surface area compared to the baseline (mean, SD). Local therapy reduced lesions from 8.5 (5.7) to 5.3 (4.2) by 37.3% (p < 0.0001), phototherapy reduced lesions from 9.8 (5.4) to 5.7 (3.92) by 42.3% (p < 0.0001), and combined therapy reduced lesions from 14.2 (4.8) to 6.58 (3.5) by 53.6% (p < 0.0001), with combined therapy showing superior numerical efficacy. Clinical efficacy for CNI monotherapy was 67.4%, for phototherapy — 80.5%, and for combined therapy 93.7%. The safety profile of therapies was consistent with other studies. Our results support the use of combined therapy in vitiligo patients.

Keywords

Abyaneh, M. Y., Griffith, R. D., Falto-Aizpurua, L., Nouri, K. (2014). Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: Mechanisms and efficacies. J. Eur. Acad. Dermatol. Venereol., 28, 1610–1622. Search in Google Scholar

Alikhan, A., Felste,, L. M., Daly, M., Petronic-Rosic, V. (2011). Vitiligo: A comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histpathology, etiology, and work-up. J. Amer. Acad. Dermatol., 65, 473–491. Search in Google Scholar

Brazzeli, V., Prestinari, F. (2005). Useful treatment of vitiligo in 10 children with UV-B-narrow-band (311 nm). Pediatr. Dermatol., 22, 257–261. Search in Google Scholar

Chen, G. Y., Hsu, M. M., Tai, H. K. (2005). Narrow-band UVB treatment of vitiligo in Chinese. J. Dermatol., 10, 793–800. Search in Google Scholar

Cui, J., Shen, L. Y., Wang, G. C. (1991). Role of hair follicles in the repigmentation of vitiligo. J. Invest. Dermatol., 97, 410–416. Search in Google Scholar

Esfandiarpour, I., Ekhlasi, A., Farajzadeh, S., Shamsadini, S. (2009). The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: A double- blind, placebo-controlled clinical trial. J. Dermatol. Treat., 20, 14–18. Search in Google Scholar

Fai, D., Cassano, N., Vena, G. A. (2007). Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: A review of 110 patients. J. Eur. Acad. Dermatol. Venereol., 21, 916–920. Search in Google Scholar

Gawkrodger, D. J., Ormerod, A. D., Shaw, L., Mauri-Sole, I., Whitton, M. E., Watts, M. J. (2008). Guideline for the diagnosis and management of vitiligo. Brit. J. Dermatol., 159, 1051–1076. Search in Google Scholar

Grimes, P. E., Morris, R., Avaniss-Aghajani, E., Soriano, T., Meraz, M., Metzger, A. (2004). Topical tacrolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J. Amer. Acad. Dermatol., 51, 52–61. Search in Google Scholar

Hirobe, T. (2005). Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res., 18, 2–12. Search in Google Scholar

Iannella, G., Greco, A., Didon, D., Didona, B., Granata, G., Manno, A., Pasquariello, B., Magliulo, G. (2016). Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmun. Rev., 15, 335–343. Search in Google Scholar

Kang, H. Y., Choi, Y. M. (2009). FK 506 increases pigmentation and migration of human melanocytes. Brit. J. Dermatol., 155, 1037–1040. Search in Google Scholar

Kanwar, A. J., Dogra, S. (2006). Narrow-band UVB for the treatment of generalized vitiligo in children. Clin. Exp. Dermatol., 45, 63–65. Search in Google Scholar

Klahan, S., Asawanonda, P. (2009). Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: A randomized, controlled study. Clin. Exp. Dermatol., 34, 1029–1030. Search in Google Scholar

Lan, C. C., Che, G. S., Chiou, M. H., Wu, C. S., Chang, C. H., Yu, H. S. (2005a). FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: Possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Brit. J. Dermatol., 153 (3), 498–505. Search in Google Scholar

Lan, C. C., Chen, G. S., Chiou, M. H. (2005b). FK 506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes. Brit. J. Dermatol., 153, 496–505. Search in Google Scholar

Lee, K. Y., Jeon, S. Y., Hong, J. W., Choi, K. W., Lee, C. Y., Choi, S. J., Kim, J. H., Song, K. H., Kim, K. H. (2013). Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: A proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment. J. Eur. Acad. Dermatol. Venereol., 27, 609–616. Search in Google Scholar

Lotti, T., Buggiani, G., Troiano, M. (2008). Targeted and combination treatment for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol. Ther., 21, 20–S26. Search in Google Scholar

Majid, I. (2010). Does topical tacrolimus ointment enhance the efficacy of narrow-band ultraviolet B therapy in vitiligo? A left-right comparison study. Photodermatol. Photoimmunol. Photomed., 26, 230–234. Search in Google Scholar

Mehrabi, D., Pandya, A. G. (2006). A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch. Dermatol., 142, 927–929. Search in Google Scholar

Moretti, S., Spallanzani, A., Amato, L., Hautmann, G., Gallerani, I., Fabiani, M. (2002). New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res., 15, 87–92. Search in Google Scholar

Njoo, M., Bos, M. S., Westerhof, W. (2000). Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J. Amer. Acad. Dermatol., 42, 245–253. Search in Google Scholar

Nordal, E. J., Guleng, G. E., Rönnevig, J. R. (2011). Treatment of vitiligo with narrowband-UVB (TL 01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. J. Eur. Acad. Dermatol. Venereol., 25, 1440–1443. Search in Google Scholar

Ongenae, K., Beelaert, L., van Geel, N., Naeyaert, J. M. (2006). Psychosocial effects of vitiligo. J. Eur. Acad. Dermatol. Venereol., 20, 1–8. Search in Google Scholar

Ponsonby, A. L., Lucas, R. M., van der Mei, I. A. (2005). UVR, vitamin D and three autoimmune diseases — multiple sclerosis, type I diabetes, rheumatoid arthritis. Photochem. Photobiol., 81, 1267–1275. Search in Google Scholar

Satyanarayan, H. S., Kanwar, J. A., Parsad, D., Vinay, K. (2013). Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: A randomized intra-individual open comparative trial. Indian J. Dermatol. Venereol. Leprol., 79, 525–527. Search in Google Scholar

Seirafi, H., Farnaghi, F., Firooz, A., Vasheghani-Farahani, A., Allirezale, N. S., Dowlati, Y. (2007). Pimecrolimus cream in repigmentation of vitiligo. Dermatology, 214, 253–259. Search in Google Scholar

Senft, D., Ronai, Z. A. (2016). Immunogenic, cellular, and angiogenic drivers of tumour dormancy: A melanoma view. Pigment Cell Melanoma Res., 1, 27–42. Search in Google Scholar

Sisti, A., Sisti, G., Oranges, C. M (2016). Effectiveness and safety of topical tacrolimus for repigmentation in vitiligo: A comprehensive literature review. An. Bras. Dermatol., 91, 187–195. Search in Google Scholar

Taieb, A., Alomar, A., Böhm, M., Dell’anna, M. L., De Pase, A., Eleftheriadou, V., Ezzedine, K., Gauthier, Y., Gawkrodger, D. J., Jouary, T. (2013). Guidelines for the management of vitiligo: The European Dermatology Forum consensus. Brit. J. Dermatol., 168, 5–19. Search in Google Scholar

Taieb, A., Picardo, M. (2010). Epidemiology, definitions and classification. In: Vitiligo. Springer, Berlin-Heidelberg, pp. 13–24. Search in Google Scholar

Taieb, A., Picardo, M., VETF Members (2007). The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force. Pigment Cell Res., 20, 27–35. Search in Google Scholar

Taieb, A., Picardo, M. (2009). Clinical practice: Vitiligo. New Eng. J. Med., 360, 160–169. Search in Google Scholar

Tran, C., Lubbe, J., Sorg, O. (2005). Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hair less mouse epidermis. Dermatology, 211, 341–347. Search in Google Scholar

Westerhof, W., d’Ischia, M. (2007). Vitiligo puzzle: The pieces fall in place. Pigment Cell Res., 20, 345–359. Search in Google Scholar

Whitton, M. E., Pinart, M., Batchelor, J., Lushe, C., Leonardi-Bee, J., González, U. (2010). Interventions for vitiligo. Cochrane Database Syst. Rev., 20 (1), CD003263. Search in Google Scholar

Wu, C. S., Yu, C. L., Lan, C. C. E., Yu, H. S. (2004). Narrow-band ultraviolet B stimulates proliferation and migration of cultured melanocytes. Exp. Dermatol., 13, 755–763. Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo